Evidence map›Paper›PMID 42159289›Full record

ReviewJournal of virology2026

Unraveling the layers of epigenetic control in respiratory antiviral defense.

Matthew I McFadden, Bryan Simo, Adriana Forero

Abstract readReview
In one paragraph

Review in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew I McFaddenDepartment of Microbial Infection and Immunity, Infectious Diseases Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0009-0005-4955-7111
Bryan SimoDepartment of Microbial Infection and Immunity, Infectious Diseases Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Adriana ForeroDepartment of Microbial Infection and Immunity, Infectious Diseases Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0000-0002-2698-658X

Funding

Identification of novel type III IFN regulatory pathwaysR35GM150806 · NIGMS · OHIO STATE UNIVERSITY · PI Adriana Forero · 2023 to 2026
$1.6M
American Heart Association 25PRE1361452Burroughs Wellcome Fund 1173942NIGMS NIH HHS R35 GM150806NIH HHS 5T32AI165391NIH HHS R35GM150806
6 · The paper itself

Abstract

The host defense against emerging respiratory pathogens begins with the induction of cell-intrinsic, interferon-mediated antiviral responses. The interferon response induces innate effector and adaptive cellular responses crucial for viral clearance and the establishment of long-lasting immune memory. Although these antiviral processes are primarily characterized at the transcriptional level, the epigenetic mechanisms that orchestrate the cellular transcriptional output during infection remain understudied. Technological advances in systems immunology and virology have revealed dynamic changes in the cellular epigenetic landscape following infection, and their contextual roles in the fine-tuning of antiviral defense. This minireview covers our current understanding of how DNA methylation, post-translational modifications of histones, and chromatin remodelers are dynamically reprogrammed during respiratory virus infections, and the distinct strategies that respiratory viruses employ to subvert epigenetic control. We place further emphasis on cell-type-specific programs and the biological factors that alter the epigenetic landscape and regulate the balance between protective or pathogenic immune responses to infection.

Indexed as

Epigenesis, GeneticHost-Pathogen InteractionsRespiratory Tract InfectionsVirus DiseasesAnimalsChromatin Assembly and DisassemblyDNA MethylationHistonesHumansImmunity, InnateInterferonsProtein Processing, Post-TranslationalTrained ImmunityHistonesInterferonsepigeneticshost responseinterferonsrespiratory pathogens

Identifiers

PMID42159289
PMCPMC13267732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.